» Authors » T O Tengs

T O Tengs

Explore the profile of T O Tengs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 480
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tengs T, Osgood N, Chen L
Prev Med . 2001 Nov; 33(6):558-70. PMID: 11716651
Objectives: School-based anti-tobacco education using the "social influences" model is known to reduce smoking among youth by 5-56%. Program effectiveness, however, dissipates in 1-4 years. Consequently, opinion leaders have questioned...
2.
Tengs T, Osgood N, Lin T
Med Care . 2001 Sep; 39(10):1131-41. PMID: 11567175
Objectives: The relative magnitude of the public health gains from preventing smoking initiation versus encouraging cessation or avoiding relapse in different ages and genders is estimated and compared. Methods: Health...
3.
Tengs T, Osgood N
Prev Med . 2001 Jun; 32(6):447-52. PMID: 11394947
Background: Anti-tobacco advertisements now feature the risk of impotence as a reason to avoid or cease tobacco use. The scientific evidence, however, is mixed. To shed light on the controversy,...
4.
Tengs T, Yu M, Luistro E
Stroke . 2001 Apr; 32(4):964-72. PMID: 11283398
Background And Purpose: We performed a comprehensive review of all quality-of-life (QOL) estimates for stroke appearing in the peer-reviewed literature between 1985 and 2000. We examine variation in QOL weights...
5.
Tengs T, Wallace A
Med Care . 2000 Jun; 38(6):583-637. PMID: 10843310
Objective: Analysts performing cost-effectiveness analyses often do not have the resources to gather original quality-of-life (QOL) weights. Furthermore, variability in QOL for the same health state hampers the comparability of...
6.
Tengs T, Winer E, Paddock S, Berry D
Med Decis Making . 1999 Jun; 18(4):365-75. PMID: 10372578
Objective: The authors developed a Markov decision model to evaluate the health implications of testing for mutations in the BRCA1 and BRCA2 breast-ovarian cancer susceptibility genes. Prophylactic measures considered included...
7.
Tengs T
Acad Radiol . 1999 Jan; 6 Suppl 1:S120-7. PMID: 9891179
No abstract available.
8.
Tengs T
Health Econ . 1996 May; 5(3):171-81. PMID: 8817293
No abstract available.
9.
Tengs T, Meyer G, Siegel J, Pliskin J, Graham J, Weinstein M
Med Decis Making . 1996 Apr; 16(2):99-107. PMID: 8778541
The authors examine whether Oregon's 1990, 1991, 1992, and 1993 prioritized lists were ranked in a manner consistent with cost-effectiveness. Two sets of cost-effectiveness data are used: data from economic...
10.
Tengs T, Adams M, Pliskin J, Safran D, Siegel J, Weinstein M, et al.
Risk Anal . 1995 Jun; 15(3):369-90. PMID: 7604170
We gathered information on the cost-effectiveness of life-saving interventions in the United States from publicly available economic analyses. "Life-saving interventions" were defined as any behavioral and/or technological strategy that reduces...